Guan Qi, Cheng Zengjin, Ma Xiaoxue, Wang Lijie, Feng Dongjie, Cui Yuanhang, Bao Kai, Wu Lan, Zhang Weige
Key Laboratory of Structure-based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Department of Geratology, The First Affiliated Hospital, China Medical University, Shenyang 110001, China.
Eur J Med Chem. 2014 Oct 6;85:508-16. doi: 10.1016/j.ejmech.2014.08.014. Epub 2014 Aug 6.
A series of 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acid derivatives (8a-f, 9a-m) were synthesized and evaluated for inhibitory activity against xanthine oxidase in vitro. Structure-activity relationship analyses have also been presented. Most of the target compounds exhibited potency levels in the nanomolar range. Compound 9e emerged as the most potent xanthine oxidase inhibitor (IC50 = 5.5 nM) in comparison to febuxostat (IC50 = 18.6 nM). Steady-state kinetics measurements with the bovine milk enzyme indicated a mixed type inhibition with Ki and Ki' values of 0.9 and 2.3 nM, respectively. A molecular modeling study on compounds 9e was performed to gain an insight into its binding mode with xanthine oxidase, and to provide the basis for further structure-guided design of new non-purine xanthine oxidase inhibitors related with 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acid scaffold.
合成了一系列2-苯基-4-甲基-1,3-硒唑-5-羧酸衍生物(8a-f,9a-m),并对其体外抗黄嘌呤氧化酶的抑制活性进行了评估。还进行了构效关系分析。大多数目标化合物的活性水平在纳摩尔范围内。与非布索坦(IC50 = 18.6 nM)相比,化合物9e成为最有效的黄嘌呤氧化酶抑制剂(IC50 = 5.5 nM)。对牛乳酶进行的稳态动力学测量表明为混合型抑制,Ki和Ki'值分别为0.9和2.3 nM。对化合物9e进行了分子模拟研究,以深入了解其与黄嘌呤氧化酶的结合模式,并为进一步基于结构设计与2-苯基-4-甲基-1,3-硒唑-5-羧酸支架相关的新型非嘌呤黄嘌呤氧化酶抑制剂提供依据。